AcquisitionOther

AVEO PHARMACEUTICALS, INC. acquired AVEO Oncology

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

AVEO PHARMACEUTICALS, INC. -> AVEO Oncology · $571M

“We are excited to complete LG Chem’s acquisition of AVEO, which will position us to deliver on our mission of becoming one of the world’s leading oncology companies with a robust clinical pipeline of innovative therapies,” said Shin Hak-Cheol, Chief Executive

Open source record (SEC) ↗